Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors
Zhengyan Kan(Pfizer (United States)), Jadwiga Biénkowska(Pfizer (United States))
Cited by 13
Related Papers
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
|Nature Genetics|2011|775
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
|Genome Research|2013|530